ArticleFrontiers in oncology2023

Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab.

Andrea Duminuco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.